CL2007003641A1 - COMPOUNDS DERIVED FROM PIPERIDINE REPLACED WITH CONDENSED HETEROCICLES, USEFUL IN THE TREATMENT OF BACTERIAL INFECTIONS. - Google Patents

COMPOUNDS DERIVED FROM PIPERIDINE REPLACED WITH CONDENSED HETEROCICLES, USEFUL IN THE TREATMENT OF BACTERIAL INFECTIONS.

Info

Publication number
CL2007003641A1
CL2007003641A1 CL200703641A CL2007003641A CL2007003641A1 CL 2007003641 A1 CL2007003641 A1 CL 2007003641A1 CL 200703641 A CL200703641 A CL 200703641A CL 2007003641 A CL2007003641 A CL 2007003641A CL 2007003641 A1 CL2007003641 A1 CL 2007003641A1
Authority
CL
Chile
Prior art keywords
heterocicles
condensed
useful
treatment
bacterial infections
Prior art date
Application number
CL200703641A
Other languages
Spanish (es)
Inventor
Janelle Cronin Comita-Prevoir
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39046831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007003641(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CL2007003641A1 publication Critical patent/CL2007003641A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
CL200703641A 2006-12-15 2007-12-14 COMPOUNDS DERIVED FROM PIPERIDINE REPLACED WITH CONDENSED HETEROCICLES, USEFUL IN THE TREATMENT OF BACTERIAL INFECTIONS. CL2007003641A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87018106P 2006-12-15 2006-12-15
US96916307P 2007-08-30 2007-08-30

Publications (1)

Publication Number Publication Date
CL2007003641A1 true CL2007003641A1 (en) 2008-09-22

Family

ID=39046831

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200703641A CL2007003641A1 (en) 2006-12-15 2007-12-14 COMPOUNDS DERIVED FROM PIPERIDINE REPLACED WITH CONDENSED HETEROCICLES, USEFUL IN THE TREATMENT OF BACTERIAL INFECTIONS.

Country Status (17)

Country Link
EP (1) EP2121702A1 (en)
JP (1) JP2010513255A (en)
KR (1) KR20090090385A (en)
AR (1) AR064369A1 (en)
AU (1) AU2007331247B2 (en)
BR (1) BRPI0720236A2 (en)
CA (1) CA2671485A1 (en)
CL (1) CL2007003641A1 (en)
CO (1) CO6190619A2 (en)
EC (1) ECSP099506A (en)
MX (1) MX2009006325A (en)
NO (1) NO20092655L (en)
PE (1) PE20081511A1 (en)
RU (1) RU2009126731A (en)
TW (1) TW200831517A (en)
UY (1) UY30788A1 (en)
WO (1) WO2008071961A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2006137485A1 (en) 2005-06-24 2006-12-28 Toyama Chemical Co., Ltd. Novel nitrogenated heterocyclic compound and salt thereof
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
WO2010041218A2 (en) 2008-10-10 2010-04-15 Actelion Pharmaceuticals Ltd Oxazolidinyl antibiotics
AR076222A1 (en) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd DERIVATIVES 2-HYDROXIETIL-1H-QUINOLIN-ONA AND ITS AZAISOTHERAL ANALOGS WITH ANTIBACTERIAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO2012045150A1 (en) * 2010-10-04 2012-04-12 British Columbia Cancer Agency Branch Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
CN117466803A (en) 2017-08-21 2024-01-30 阿卡蒂亚药品公司 Compounds, salts thereof and methods for treating diseases
EP3672960A2 (en) * 2017-08-21 2020-07-01 Acadia Pharmaceuticals Inc. Compounds, salts thereof and their use for the treatment of diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601265A1 (en) * 1996-01-16 1997-07-17 Bayer Ag 2-oxo and 2-thio-1,2-dihydroquinolinyl oxazolidinones
AR040336A1 (en) * 2002-06-26 2005-03-30 Glaxo Group Ltd PIPERIDINE COMPOUND, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND PROCEDURE TO PREPARE SUCH COMPOUND
JP5314244B2 (en) * 2004-10-27 2013-10-16 富山化学工業株式会社 Novel nitrogen-containing heterocyclic compounds and salts thereof
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2006137485A1 (en) * 2005-06-24 2006-12-28 Toyama Chemical Co., Ltd. Novel nitrogenated heterocyclic compound and salt thereof
KR101409261B1 (en) * 2006-05-26 2014-06-18 다이쇼 세이야꾸 가부시끼가이샤 Novel heterocyclic compound or salt thereof and intermediate thereof
EP2029612A1 (en) * 2006-06-09 2009-03-04 Glaxo Group Limited Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
JP5315239B2 (en) * 2006-07-20 2013-10-16 グラクソ グループ リミテッド N-ethylquinolone and derivatives and analogs of N-ethylazaquinolone
EP1992628A1 (en) * 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones

Also Published As

Publication number Publication date
EP2121702A1 (en) 2009-11-25
AU2007331247B2 (en) 2011-10-20
WO2008071961A1 (en) 2008-06-19
JP2010513255A (en) 2010-04-30
WO2008071961A8 (en) 2009-10-22
AU2007331247A1 (en) 2008-06-19
TW200831517A (en) 2008-08-01
RU2009126731A (en) 2011-01-20
PE20081511A1 (en) 2008-12-12
BRPI0720236A2 (en) 2013-12-24
NO20092655L (en) 2009-09-02
MX2009006325A (en) 2009-07-24
CO6190619A2 (en) 2010-08-19
AR064369A1 (en) 2009-04-01
ECSP099506A (en) 2009-08-28
UY30788A1 (en) 2008-07-31
KR20090090385A (en) 2009-08-25
CA2671485A1 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
DK2041123T3 (en) Condensed cyclic compounds.
NL2000581A1 (en) Condensed phenylamidoheterocyclic compounds.
DE602007009284D1 (en) 3-AZA-BICYCLOÄ3.1.0ÜHEXANDERIVATE
BRPI0819780A2 (en) Recombinantly modified plasma.
SMP200900085B (en) 3-imidazolyl-indoles for the treatment of malolysiseproliferative.
BRPI0815773A2 (en) compound and medicine.
BRPI0815717A2 (en) IMIDAZYPIRAZINE COMPOUNDS.
FR2909857B1 (en) Endovalve.
BRPI0816970A2 (en) 1,3-disubstituted-4-phenyl-1h-pyridin-2-ones
WO2008115281A3 (en) Compounds for treating viral infections
CL2007003641A1 (en) COMPOUNDS DERIVED FROM PIPERIDINE REPLACED WITH CONDENSED HETEROCICLES, USEFUL IN THE TREATMENT OF BACTERIAL INFECTIONS.
DK2035398T3 (en) Immobilized 1,2-benzisothioazolin-3-one
DK2205562T3 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropanderivater
DE602007001681D1 (en) 1,3-dioxane-Carboxylic
CL2008000629A1 (en) MACROCICLICAL COMPOUNDS DERIVED FROM 6-ARIL-4-MERCAPTO- [1.3.5] TRIAZINA / [1.3] PIRIMIDIN-2-AMINA; PHARMACEUTICAL COMPOSITION, USEFUL IN THE TREATMENT OF CANCER.
BRPI0810203A2 (en) CYCLIC PEPTIDE COMPOUNDS.
BRPI0815059A2 (en) 1,3-DI-HYDROISOINDOL DERIVATIVE
CL2007001542A1 (en) COMPOUNDS DERIVED FROM AMINOTIAZOLES, PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF BACTERIAL INFECTIONS.
BRPI0916395A2 (en) 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds
FR2923713B1 (en) EPAISSY REDUCING COMPOSITION.
BRPI0812460A2 (en) "ORGANIC COMPOUNDS".
BRPI0913181A2 (en) mycobacterial infections.
BRPI1011720A2 (en) 1,1,1-trifluoro-2-hydroxypropyl compounds.
FR2908972B1 (en) VACUUM SUCKER.
BRPI0818848A2 (en) 2,3-DI-IDRO-BENZOFURAN COMPOUNDS